Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
February 07, 2024 09:15 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year...
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 05, 2024 16:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president...
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
December 13, 2023 06:15 ET
|
Integra LifeSciences Holdings Corporation
The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the...
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors
December 12, 2023 12:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Jeff Graves, Ph.D.,...
Integra LifeSciences Reports Third Quarter 2023 Financial Results
October 25, 2023 06:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences to Host Third Quarter 2023 Financial Results Conference Call on October 25, 2023
October 04, 2023 08:00 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2023 financial...
Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
September 01, 2023 17:04 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief...
Integra LifeSciences Reports Second Quarter 2023 Financial Results
July 26, 2023 18:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences to Host Second Quarter 2023 Financial Results Conference Call on July 27, 2023
July 03, 2023 16:45 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., July 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2023 financial...
Integra LifeSciences Announces Complete Enrollment in DuraSorb® Monofilament Mesh U.S. IDE Study
June 28, 2023 16:15 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., June 28, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, announced the completion of patient enrollment...